Table 1.
Primer Name | Use | Sequence (5′–3′) |
---|---|---|
CMVpF | MF1-F | CGCTGATACCGCCGCTATTAATAGTAATCAATTACGGGGTCAT |
M-CoV6, 000R | MF1-R | ATTCTTATAAATAGGGTCATAAGTGTCAAACTCAGCCAACA |
M-CoV6, 001F | MF2-F | GTTGGCTGAGTTTGACACTTATGACCCTATTTATAAGAATGGT |
M-CoV18, 000R | MF2-R | GGCCAGTTACAATCTGAGACTGGAGCTTGTAATTAGTAAAAGA |
M-CoV18, 001F | MF3-F | TCTTTTACTAATTACAAGCTCCAGTCTCAGATTGTAACTGGCC |
BGTR | MF3-R | TTAACTGCGGCGAGGCAGCATATGGCATATGTTGCCAAACTCTAAACCAAATAC |
pYES1L F | Vector | CATATGCCATATGCTGCCTCGCCGCAGTTAATTAAAGTCA |
pYES1L R | Vector | TGATTACTATTAATAGCGGCGGTATCAGCG |
Primers containing ∼ 30 bps of homology between MERS-CoV cDNA fragments (MF1, MF2 and MF3) and the pYES1L-BAC vector were used to amplify the regions in preparation for assembly by homologous recombination.